XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Collaborative Research and License Agreements (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 13, 2019
USD ($)
agreement
Feb. 17, 2019
USD ($)
collaborationTarget
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Collaboration revenue     $ 2,443 $ 527 $ 16,473 $ 986  
Deferred revenue, current     8,479   8,479   $ 21,873
AbbVie Collaboration | Collaboration Arrangement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Number of collaboration programs | agreement 2            
Non-refundable upfront payment received for research agreement $ 25,000            
Collaboration option exercise fee 10,000            
Collaboration option exercise fee $ 10,000            
Termination period upon written notice 90 days            
Collaboration revenue     2,402   16,351    
Deferred revenue, current     8,479   8,479    
Dermelix License Agreement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Aggregate regulatory milestone revenue   $ 13,500          
Potential milestone revenue   152,500          
Dermelix License Agreement | Collaboration Arrangement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Non-refundable upfront payment received for research agreement   1,000          
Collaboration option exercise fee   $ 1,000          
Collaboration revenue     $ 41 $ 527 $ 122 $ 986  
Number of additional collaboration targets | collaborationTarget   5          
Collaboration agreement term   6 years          
Collaboration development expenses   $ 1,000          
Collaboration option rights usage term   30 days          
Development and Commercialization License | AbbVie Collaboration | Collaboration Arrangement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Collaboration option exercise fee $ 15,000            
Maximum | AbbVie Collaboration | Collaboration Arrangement              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Development milestone payment 55,000            
Product approval and launch milestone payment 132,500            
Sales milestone payment $ 175,000